These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32856199)

  • 1. Lipid chaperones and associated diseases: a group of chaperonopathies defining a new nosological entity with implications for medical research and practice.
    D'Anneo A; Bavisotto CC; Gammazza AM; Paladino L; Carlisi D; Cappello F; de Macario EC; Macario AJL; Lauricella M
    Cell Stress Chaperones; 2020 Nov; 25(6):805-820. PubMed ID: 32856199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms in chaperonopathies: clues to understanding the histopathological abnormalities and developing novel therapies.
    Macario AJ; de Macario EC
    J Pathol; 2020 Jan; 250(1):9-18. PubMed ID: 31579936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population.
    Zhang Y; Kent JW; Lee A; Cerjak D; Ali O; Diasio R; Olivier M; Blangero J; Carless MA; Kissebah AH
    BMC Med Genomics; 2013 Mar; 6():9. PubMed ID: 23510163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperonopathies and chaperonotherapy.
    Macario AJ; Conway de Macario E
    FEBS Lett; 2007 Jul; 581(19):3681-8. PubMed ID: 17475257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperonopathies by defect, excess, or mistake.
    Macario AJ; Conway de Macario E
    Ann N Y Acad Sci; 2007 Oct; 1113():178-91. PubMed ID: 17483209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of fatty acid binding proteins (FABPs) in cancer development and progression.
    McKillop IH; Girardi CA; Thompson KJ
    Cell Signal; 2019 Oct; 62():109336. PubMed ID: 31170472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
    Furuhashi M
    J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy.
    Marino Gammazza A; Bavisotto CC; Barone R; de Macario EC; Macario AJ
    Curr Pharm Des; 2016; 22(26):4040-9. PubMed ID: 27189602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multipronged Method for Unveiling Subtle Structural-Functional Defects of Mutant Chaperone Molecules Causing Human Chaperonopathies.
    Bulone D; San Biagio PL; Quiñones-Ruiz T; Rosario-Alomar M; Lednev IK; Robb FT; Conway de Macario E; Macario AJL
    Methods Mol Biol; 2019; 1873():69-92. PubMed ID: 30341604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic fatty acid-binding proteins in metabolic diseases and cancers.
    Basak S; Mallick R; Banerjee A; Pathak S; Duttaroy AK
    Adv Protein Chem Struct Biol; 2022; 132():143-174. PubMed ID: 36088074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP-molecular chaperones in cancer biogenesis and tumor therapy: an overview.
    Rappa F; Farina F; Zummo G; David S; Campanella C; Carini F; Tomasello G; Damiani P; Cappello F; DE Macario EC; Macario AJ
    Anticancer Res; 2012 Dec; 32(12):5139-50. PubMed ID: 23225410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of fatty acid-binding proteins in adult hippocampal neurogenic niche of postischemic monkeys.
    Boneva NB; Kaplamadzhiev DB; Sahara S; Kikuchi H; Pyko IV; Kikuchi M; Tonchev AB; Yamashima T
    Hippocampus; 2011 Feb; 21(2):162-71. PubMed ID: 20014382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers.
    Amiri M; Yousefnia S; Seyed Forootan F; Peymani M; Ghaedi K; Nasr Esfahani MH
    Gene; 2018 Nov; 676():171-183. PubMed ID: 30021130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chaperone system in cancer therapies: Hsp90.
    Basset CA; Conway de Macario E; Leone LG; Macario AJL; Leone A
    J Mol Histol; 2023 Apr; 54(2):105-118. PubMed ID: 36933095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Chaperones and Thyroid Cancer.
    Paladino L; Vitale AM; Santonocito R; Pitruzzella A; Cipolla C; Graceffa G; Bucchieri F; Conway de Macario E; Macario AJL; Rappa F
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SnapShot: FABP Functions.
    Li B; Hao J; Zeng J; Sauter ER
    Cell; 2020 Aug; 182(4):1066-1066.e1. PubMed ID: 32822569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty-Acid-Binding Proteins: From Lipid Transporters to Disease Biomarkers.
    Gaffar S; Aathirah AS
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the structures, functions and evolution of two abundant gastrointestinal fatty acid binding proteins with recombinant DNA and computational techniques.
    Gordon JI; Lowe JB
    Chem Phys Lipids; 1985 Aug; 38(1-2):137-58. PubMed ID: 3840724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose.
    Hyder A; Zenhom M; Klapper M; Herrmann J; Schrezenmeir J
    Islets; 2010; 2(3):174-84. PubMed ID: 21099311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.
    Furuhashi M; Hotamisligil GS
    Nat Rev Drug Discov; 2008 Jun; 7(6):489-503. PubMed ID: 18511927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.